Shandong Buchang Pharmaceuticals Co (SHSE:603858) Long-Term Capital Lease Obligation : ¥9 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Long-Term Capital Lease Obligation?

Shandong Buchang Pharmaceuticals Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥9 Mil.

Shandong Buchang Pharmaceuticals Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (¥18 Mil) to Dec. 2023 (¥12 Mil) and declined from Dec. 2023 (¥12 Mil) to Mar. 2024 (¥9 Mil).

Shandong Buchang Pharmaceuticals Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (¥19 Mil) to Dec. 2022 (¥26 Mil) but then declined from Dec. 2022 (¥26 Mil) to Dec. 2023 (¥12 Mil).

Shandong Buchang Pharmaceuticals Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Long-Term Capital Lease Obligation Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

26.85

19.14

26.37

11.58

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															22.96	21.45	17.56	11.58	8.56

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shandong Buchang Pharmaceuticals Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000

Website

http://www.buchang.com

Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines